Pneumococcal immunization with conjugate vaccines - are 10-valent and 13-valent vaccines similar?

被引：0
|
作者：
Vyse, Andrew [1 ]
Theilacker, Christian [2 ]
Sings, Heather [2 ]
Fletcher, Mark [3 ]
机构：
[1] Pfizer Ltd, Vaccines Med, Surrey, England
[2] Pfizer Inc, Vaccines Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA
[3] Pfizer Inc, Emerging Markets Med, Paris, France
来源：
FUTURE MICROBIOLOGY | 2020年 / 15卷 / 08期
关键词：
differentiation; immunogenicity; invasive pneumococcal disease; PCV10; PCV13; pneumococcal disease; DISEASE;
D O I：
10.2217/fmb-2019-0310
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：575 / 578
页数：4
相关论文
共 50 条
  • [41] Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children
    Ayieko, Philip
    Griffiths, Ulla K.
    Ndiritu, Moses
    Moisi, Jennifer
    Mugoya, Isaac K.
    Kamau, Tatu
    English, Mike
    Scott, J. Anthony G.
    [J]. PLOS ONE, 2013, 8 (06):
  • [42] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV) Versus 10-Valent PCVs in Filipino Infants
    Perdrizet, J.
    Horn, E.
    Nua, W.
    Perez Peralta, J.
    Nailes, J.
    Santos, J.
    Ong-Lim, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S118 - S118
  • [43] Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada
    Wilson, Michele
    Wasserman, Matt
    Jadavi, Taj
    Postma, Maarten
    Breton, Marie-Claude
    Peloquin, Francois
    Earnshaw, Stephanie
    McDade, Cheryl
    Sings, Heather
    Farkouh, Raymond
    [J]. INFECTIOUS DISEASES AND THERAPY, 2018, 7 (03) : 353 - 371
  • [44] Prognoses of patients undergoing hemodialysis administered 23-valent pneumococcal polysaccharide versus 13-valent pneumococcal protein conjugate vaccines
    Yamaguchi, Kosei
    Kitamura, Mineaki
    Takazono, Takahiro
    Hashiguchi, Junichiroh
    Funakoshi, Satoshi
    Mukae, Hiroshi
    Nishino, Tomoya
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (12) : 1126 - 1131
  • [45] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
    Huang, Li-Min
    Lin, Tzou-Yien
    Juergens, Christine
    [J]. VACCINE, 2012, 30 (12) : 2054 - 2059
  • [46] Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
    Perdrizet, Johnna
    Santana, Carlos Felipe S.
    Senna, Thais
    Alexandre, Rodrigo Fernandes
    de Almeida, Rodrigo Sini
    Spinardi, Julia
    Wasserman, Matt
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 1162 - 1172
  • [47] Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
    Ansaldi, Filippo
    Pugh, Sarah
    Amicizia, Daniela
    Di Virgilio, Roberto
    Trucchi, Cecilia
    Orsi, Andrea
    Zollo, Alessandro
    Icardi, Giancarlo
    [J]. PATHOGENS, 2020, 9 (02):
  • [48] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN CROATIA NATIONAL VACCINATION PROGRAM
    Tichopad, A.
    Pecen, L.
    Roberts, C. S.
    Uglesic, L.
    Tesovic, G.
    Rogier, K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [49] Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly
    Kislaya, Irina
    Rodrigues, Ana Paula
    Sousa-Uva, Mafalda
    Gomez, Veronica
    Goncalves, Paulo
    Froes, Filipe
    Nunes, Baltazar
    [J]. PLOS ONE, 2019, 14 (01):
  • [50] Routine infant immunization with the 7- and 13-valent pneumococcal conjugate vaccines: current perspective on reduced-dosage regimens
    Jackowska, Teresa
    Pluta, Justyna
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) : 542 - 548
12345